Yue Xu
- Cancer Research top 5%
- MicroRNA in disease regulation 4
- Cancer, Lipids, and Metabolism 4
- Immunology top 10%
- Reproductive System and Pregnancy 3
-
- Ferroptosis and cancer prognosis 10
- Renal cell carcinoma treatment 9
-
- Epigenetics and DNA Methylation 6
- Renal and related cancers 4
- CRISPR and Genetic Engineering 3
- Oncology top 10%
In The Last Decade
Yue Xu
40 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 114
- Cancer Research 512
- Immunology 337
- Pulmonary and Respiratory Medicine 337
- Molecular Biology 690
- Oncology 267
Countries citing papers authored by Yue Xu
This map shows the geographic impact of Yue Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yue Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yue Xu more than expected).
Fields of papers citing papers by Yue Xu
This network shows the impact of papers produced by Yue Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yue Xu. The network helps show where Yue Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yue Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 0 | |
| 7 | 2025 | 1 | |
| 8 | 2025 | 0 | |
| 9 | 2025 | 2 | |
| 10 | 2024 | 0 | |
| 11 | 2023 | 2 | |
| 12 | 2022 | 9 | |
| 13 | 2022 | 17 | |
| 14 | 2022 | 31 | |
| 15 | 2020 | 13 | |
| 16 | 2020 | 31 | |
| 17 | 2020 | 20 | |
| 18 | 2019 | 39 | |
| 19 | 2019 | 21 | |
| 20 | 2015 | 137 |
About Yue Xu
Yue Xu is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Immunology, having authored 48 papers that have together received 1.2k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (10 papers), Renal cell carcinoma treatment (9 papers), Epigenetics and DNA Methylation (6 papers), MicroRNA in disease regulation (4 papers), Renal and related cancers (4 papers), Cancer, Lipids, and Metabolism (4 papers), CRISPR and Genetic Engineering (3 papers) and Reproductive System and Pregnancy (3 papers). The work is most often cited by research in Cancer Research (512 citations), Immunology (337 citations) and Pulmonary and Respiratory Medicine (337 citations). Yue Xu has collaborated with scholars based in China, Poland and Austria. Frequent co-authors include Wenhao Xu, Yuan-Yuan Qu, Hongkai Wang, Jing Yang, Che Xu, Guo-Hai Shi, Ting Zhao, Da-Long Cao, Xianmin Mu and Hao Wen. Their work appears in journals such as Water Research, Journal of Hazardous Materials and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.